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Proteins tightly bound to DNA (TBP) comprise a group of proteins that remain bound to DNA even after harsh deproteinization 
procedures. The amount of these proteins is 20–100 μg for mg of DNA depending on eukaryotic source. This experimental paper 
examines the possibility to use some TBP for clinical biomarker discovery, e.g. for identification of prognostic and diagnostic cancer 
markers. The main aim of this study was to designate differences between tightly DNA binding protein patterns extracted from rat liver 
and rat experimental hepatomas (Zajdela ascites hepatoma and hepatoma G-27) and to evaluate possibility that some of these proteins 
may be used as biomarkers for cell cancer transformation. Methods: We used  proteomics aproach as a tool for comparison of pattern 
of TBP from rat experimental hepatomas and normal liver cells. Combination of 2DE fractionation with mass spectrometry (MALDI 
TOF-MS) suitable for parallel profiling of complex TBP mixtures. Results:  Intriguingly 2DE protein maps of TBP from rat liver and 
rat experimental hepatomas (Zajdela acites hepatoma and hepatoma G-27) were quite different. We identified 9 proteins, some of them 
shared in all TBP patterns. Among identified tightly bound to DNA proteins there were three proteins considered as nuclear matrix 
proteins (lamin B1, scaffold attachment factor B1, heterogeneous nuclear ribonucleoprotein). Also we identified DNA repair protein 
RAD50, coiled-coil domain-containing protein 41, structural maintenance of chromosomes protein1A and some ATP –dependent 
RNA helicases indicating that TBP are of interest with respect to their potential involvement in the topological organization and/
or function of genomic DNA. Conclusions: We suppose that proteomic approach  for TBP identification may be promising in develop-
ment of biomarkers, also obtained results may be valuable for further understanding TBP functions in genome. 
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INTRODUCTION
Search for novel tumour markers is an important 
research branch in modern oncology. Several tumour 
markers have been found among the nuclear matrix 
proteins [1]. The nuclear matrix, operationally defined 
as nuclear structure resistant to high salt and detergent 
extraction, contains proteins that contribute to the 
preservation of nuclear shape and its organization. 
Nuclear matrix enables spatial organization of DNA 
replication, transcription and repair processes; it har-
bours numerous enzymes and transcription factors 
[2–4]. One of the bladder cancer-specific nuclear 
matrix proteins (NMP-22) was proposed for use in di-
agnostics commercial kit for its detection in urine 
is available from Matritech, Cambridge, Massachusetts. 
Utility of the marker and restrictions for its application 
are discussed in more than hundred publications [5]. 
Development of other nuclear-matrix-derived tumour 
markers is on line [6]. Nuclear matrix proteins are 
tightly bound to DNA as DNA-protein bonds in this 
structure are resistant to high salt and mild detergent 
treatments. Some researchers doubt in existence 
of nuclear matrix in living cells. Isolation procedure 
is prone to many artefacts and isolated nuclear matrix 
structures are supposed to form due to “molecular 
crowding” [7]. Another group of proteins forming tight 
complexes with DNA cannot be suspected in artefac-
tual nature due to above considerations. These are the 
so-called tightly-bound proteins (TBP). These proteins 
remain attached to DNA with covalent or non-covalent 
bonds after harsh deproteinization procedures like 
treatment with phenol, chloroform, ionic detergents, 
proteases, etc. Enrichment of the TBP in specific DNA 
sequences was a special interest with respect to spec-
ulation on the potential function of such sequences 
in higher order structures of the genome of different 
organisms including human, mouse, and chicken [8, 
9 and references therein]. Unlike nuclear matrix isolation 
procedure that is prone to many artefacts [7], TBP are 
easily isolated, their spectrum is well-reproducible. 
To our opinion the TBP are prospective for search 
of novel tumour markers. Finding of a tissue-specific 
spectrum of TBP in plants [9, 10] and animals [11] has 
encouraged us to compare spectrum of TBP in rat 
normal tissue (liver) and experimental hepatomas with 
a goal to find prospective proteins for tumor marker 
development.
MATERIALS AND METHODS 
Animals. Animals were obtained from the Labora-
tory of Experimental Animals, Riga Stradins University, 
Riga, Latvia. All experimental procedures were carried 
out in accordance with guidelines of the Directive 
86/609/EEC ”European Convention for the Protection 
of Vertebrate Animals Used for Experimental and other 
Scientific Purposes” (1986) and were approved by the 
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Animal Ethics Committee of the Food and Veterinary 
Service (Riga, Latvia). Wistar male rats, each weighing 
215.00±5.63 g at the beginning of the experiments, 
were used in all the work. The environment was main-
tained at a temperature of 22±0.5 °C with a 12-h light/
dark cycle. The animals were fed a standard laboratory 
diet. Strains of Zajdela ascites hepatoma (ZAH) and 
G-27 hepatoma were obtained from the Cancer Re-
search Centre (Moscow). 0.5 ml of ZAH ascetic liquid 
was inoculated to rats with five day interval. To passage 
the G-27 hepatoma 1 ml of tumor suspension was in-
oculated, tumor tissue was collected 14 days later [12]. 
DNA isolation. Chopped liver or hepatoma tissue 
was placed in a Dounce homogenizer, 10-fold extent 
of homogenization buffer (w/v) was added (0.25M su-
crose, 0.05M Tris-HCl, pH 7.4; 0.002M CaCl2), 10 fric-
tions were produced. Homogenate was centrifuged 
at 1000 g for 10 min. The pellet was again homogenized 
by 15 frictions  in a buffer containing 50 mM Tris-HCl 
pH 7.5; 0.25 M sucrose, 2 mM CaCl2, 1% Triton X-100. 
Crude nuclei were pelleted at 1000 g for 10 min. Ex-
traction was repeated. The nuclear pellet was mixed 
with appropriate amount of buffer (100 mM Tris HCl 
pH7.5; 500 mM NaCl, 50 mM Na2EDTA, 1.25% SDS; 
3.8 g/l of sodium bisulfite, 4ml/l of 2-mercaptoetha-
nol). Two latter components were added to the buffer 
just before the extraction to obtain a slightly viscous 
suspension. The lysate was incubated for 45 minutes 
at 65 °C. DNA was extracted with the same volume 
of chloroform/isoamylic alcohol mixture (24:1), the 
suspension was centrifuged and the water phase 
was separated. RNA was separated by precipitation 
in 4M LiCl at 4 °C for at least one hour, 12M LiCl solu-
tion was added to the water phase to reach the neces-
sary salt concentration. RNA was pelleted for 10 min 
at 10000 g. The chloroform extraction procedure of the 
supernatant was repeated again. DNA was precipitated 
from the water phase with two volumes of ethanol and 
washed in 70% ethanol.
Isolation of TBP complexes with DNA by means 
of exhaustive nuclease digestion.
The DNA was digested with DNase I (Fermentas) 
(0.01 U/g, room temperature, overnight) in 10 mM Tris-
HCl, pH 7.6; 5 mM MgCl2. Digestion was performed 
in a dialysis sack with constant dialysis against digestion 
buffer. Completeness of digestion was monitored by gel 
electrophoresis. Protein concentration was determined 
with the BCA according [13], using crystalline bovine 
serum albumine as standard [13]. Proteins were pre-
cipitated with ice-cold 10% (v/v) TCA for 1 h on ice, and 
protein pellet was washed twice with ice-cold acetone. 
Resulting pellet were dissolved in rehydration buffer 
(7M urea, 2M thiourea, 2% CHAPS, 0.5% IPG buffer, 
40 mM DTT, 0.002% bromphenol). 
2D electrophoresis  (IEF/SDS-PAGE). 
An 11 cm Immobiline DryStrips with linear pH gra-
dient 5.3–6.5, and Excel Gel SDS, gradient 8–18% 
(GE Healthcare, Piscataway, NJ,USA) were used for 
2DE. The TBP corresponding 1 mg of DNA dissolved 
in 200 l of rehydration buffer and were loaded onto 
IPG gel strip; then were reswollen overnight. The iso-
electrofocusing was carried out up to a total of 70 kVh. 
Prior to second dimension gel stripes were reduced 
and acylated according to the manufacturer’s rec-
ommendations. IEF/ SDS PAGE was performed with 
Multiphor II device (GE Healthcare, Piscataway, NJ, 
USA). Gels were silver stained according to Shevc-
henko A et al. [14].
Preparation of samples for MALDI-TOF. After 
staining, the spots of interest were excised from gel, 
crushed to 1 mm2 sized slices and dehydrated with 
50% acetonitrile.  The gel slices were then dried un-
der vacuum and rehydrated with 30 μl 25 mM NH4H-
CO3 (pH 8.3). Proteins in the gel slices were digested 
overnight with 100 ng of modified trypsin (Promega, 
Madison, WI, USA) at 37 °C. The peptides were then 
washed twice from the gel with 50 μl 5% TFA in 50% 
acetonitrile. The wash-outs were collected and dried 
under vacuum. For MALDI-TOF, peptides were diluted 
in 3 μl of 0.01% trifluoracetic acid (TFA) in 30% aceto-
nitrile. 0.8 μl of each sample with matrix (α-Cyano-4-
hydroxycinnamic acid) were loaded on MALDI plate.
MALDI-TOF (Matrix-Assisted Laser Desorp-
tion/Ionization Time-Of-Flight) analysis. Samples 
were analyzed with a MALDI–TOF MS using a Voyager-
DE™ Pro (Applied Biosystems, Framingham, MA). 
Positive ionization, acceleration voltage 20 kV, grid 
voltage 75%, guide wire 0.02 and the extraction delay 
time 200 ns were used to collect spectra in the mass 
range of 700−4000 Da. Reflector mass spectra were 
acquired and calibrated either externally or inter-
nally, using trypsin autolysis peptides (m/z 842.5200, 
1045.5642, 2211.1046).
Data processing of the spectra was performed with 
Data Explorer™ Version 4.0 (Applied Biosystems). 
Protein identification was performed by searching 
in protein sequence database (SwisPro) using Pep-
tIdent and MS-Fit programs available on the ExPaSY 
server (http://us.expasy.org/). The following param-
eters were used for databases searches: monoiso-
topic mass accuracy 50–100 ppm, missed cleavages 
0–1 and complete carbomethylation of cysteines.
RESULTS
2D electrophoresis. We screened three sepa-
rate sets of TBP for changes of the proteome. The 
separation by pI was limited to the range of 5.3–6.5 for 
a better resolution of TBP proteins. Proteins separated 
by 2D electrophoresis were visualized by staining with 
AgNO3. As seen in Figure, the resulting 2DE maps 
of tightly bound protein patterns from rat liver and rat 
experimental hepatomas (Zajdela ascites hepatoma 
and G-27 hepatoma) appeared quite different. 2DE 
TBP patterns of Zajdela ascites hepatoma (Figure, 
b) and hepatoma G-27 (Figure, c) appeared dif-
ferent also. It was expected that these proteomas 
might share similar spot patterns.  We suggest that 
protein spot pattern alterations hardly occur due 
to different protein abundance in TBP patterns. For all 
2-DE fractionations we subjected TBP amount which 
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corresponded to 1 mg of DNA. As seen in Figure, 
the least amount of TBP is characteristic for hepa-
toma G-27 cells. TBP is represented by numerous 
peptides in all TBP samples. The images of 2DE gels 
could not be readily overlapped to determine dif-
ferences. Protein spot profiles were analyzed using 
image analysis software — Melanie 7 (Swiss Institute 
of Bioinformatics). Due to the different spot pattern 
of the three sets of TBP, software matching did not 
generate useful identification of protein differences. 
Using the same spot detection parameters different 
number of spots was detected in all preparations. For 
example, comparative analysis of corresponding gel 
sections as denoted in Figure by frames (pH range 
of 5.8–6.4 and molecular mass within the range 
of 20–80 kDa)  revealed 35 spots in Zajdela acites 
hepatoma TBP pattern, 24 spots in liver TBP patern 
and 18 in hepatoma G-27 TBP pattern. Only 7 spots 
were shared among the all TBP sets. In general, the 
TBP pattern appeared to be different in normal and 
malignant tissues. Zajdela ascites hepatoma TBP pat-
tern appear to be more numerous and heterogenous. 
Fraction of proteins with lower pI is more pronounced 
in G-27 TBP pattern.
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Figure. 2D electrophoresis patterns of TBP isolated from rat liver 
cells (a), experimental Zajdela ascites hepatoma (b) and experi-
mental G-27 hepatoma (c). First dimension — Immobiline Dry 
Strips 5.3–6.5 pH; second dimension — Excel Gel SDS, gradient 
8–18%. Gels stained with AgNO3. Positions of molecular weight 
markers are indicated on the left, pH — below.  Numbers denote 
spots which were identified by MALDI-TOF. Frame denoted the 
gel section comparatively analyzed with Melanie 7
Mass spectrometric analysis. Some of protein 
spots were subjected to mass spectrometry. Our 
criteria for accepting spots for mass spectrometry 
analysis were as follows: i) due to the limited sensitivity 
of the mass spectrometer only protein spots contain-
ing no less than 1 pmol of protein were subjected 
to analysis; we selected similar spots (pI, Mw) shared 
among all TBP sets, and some spots which were pres-
ent  only in separate TBP pattern; iii) spots for analysis 
were chosen following methodological approaches for 
proteomic analysis of nuclear matrix proteins [15, 16]; 
Protein spots were cut out from the gels and sub-
jected to in gel tryptic digestion. Mass fingerprints of the 
peptide mixtures were obtained by MALDI TOF mass 
spectrometry. Protein identification was performed 
by searching in protein sequence database (SwisPro) 
using PeptIdent  and MS-Fit programs. The following 
parameters were used for databases searches: monoiso-
topic mass accuracy 50–100 ppm, missed cleavages 
0–1 and complete carbomethylation of cysteines. The list 
of proteins identified by PeptIdent program is presented 
in Table. The Table presents only proteins with a MASCOT 
total protein score > 50 so were considered as real and 
as high confidence proteins and covered  by  peptides 
at least 15% of the entire protein sequence.  
Surprisingly, we found that the resulting list of iden-
tified proteins from different TBP patterns appeared 
quite similar. We consider that such result to some 
extent is determined by our criteria of accepting spots 
for mass spectrometry and the limited sensitivity of the 
mass spectrometer.
Spots (e.g., 3, 4, 7, 8, 10) were detected as frag-
ments of identified proteins. Intriguingly similar spots 
(the same pI, Mw) from different gels contained the 
same TBP as identified by mass spectrometry. Pep-
tides from spots 3 (liver), 7 (Zajdela acites hepatoma) 
and 10 (hepatoma G-27) are identified as DNA repair 
protein RAD50. Spots 5 (Zajdela acites hepatoma) 
and 11 (hepatoma G27) are homologous to lamin B1. 
Spots 1 (liver) and 12 (hepatoma G27) contain pep-
tides homologous to coiled-coil domain-containing 
protein 41. In all above cases the spots occupy 
similar positions in all the three gels. However spots 
2 (liver; Mw≈35 kDa; pI 6.2) and 8 (hepatoma-G27; 
Mw ≈60kDa; pI 6.4) are corresponding to peptides 
of different size. It was revealed that these peptides 
are homologous to “Structural maintenance of chro-
mosomes protein 1A” in both cases. Spot 4 solely 
contained peptides homologous to ATP-dependent 
RNA helicase. Spot 9 was the only to be homologous 
to scaffold attachment factor B1.
Spots 1, 2 and 6 were found to contain two proteins 
as identified by MALDI-TOF MS.
DISCUSSION
The identified proteins in all TBP samples are nucle-
ar proteins (Table). This excludes possibly artefactual 
binding of the proteins in vitro observed in some cases 
[11, 17]. Moreover, ability to form very tight complexes 
with DNA was reported to several of these identified 
proteins.
As seen in Table some of identified proteins belong 
to nuclear matrix. Lamins, heterogeneous nuclear 
ribonucleoproteins and scaffold attachment factor 
B1 are considered as nuclear matrix proteins. The 
nuclear matrix is considered a proteinaceous structure 
spatially organizing the interphase nucleus. Neverthe-
les it was demonstrated that TBP-DNA and nuclear 
matrix-DNA complexes are different structures [9], 
most likely some of nuclear matrix proteins shared 
in TBP pattern.
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Table.  Description of TBP proteins identified after 2D electrophoresis and 
MALDI-TOF MS1. Proteins are listed with their respective SWISS-PROT pri-
mary accession numbers
Spot2 Identified Protein pI
Swiss-
Prot Ac-
cess Nr
Mass, Da
Nu
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1(A) Coiled-coil domain-containing 
protein 41
6,2 Q66H89 82 ≈60 18 18
Heterogeneous nuclear ribonu-
cleoprotein M
Q62826 56 19 18
2(A) Structural maintenance of chro-
mosomes protein 1A
6,2 Q9Z1M9 56 35 54 30
Nucleophosmin P13084 33 18 46
3(A) DNA repair protein RAD50 5,7 Q9JIL8 154 ≈35 96 47
4(B) Putative ATP-depen-dent RNA 
helicase DHX39
5,7 Q5BJS0 134 ≈38 27 20
5(B) Lamin-B1 5,4 P70615 66 66 43 48
6(B) Heterogeneous nuclear ribonu-
cleoprotein M
6,4 Q62826 74 ≈70 71 40
Structural maintenance of chro-
mosomes pr.1A
Q9Z1M9 143 28 34
7(B) DNA repair protein RAD50 5,7 Q9JIL8 154 ≈35 65 33
8(C) Structural maintenance of chro-
mosomes pr.1A
6,4 Q9Z1M9 143 60 37 18
9(C) Scaffold attachment factor B1 5,4 O88453 105 ≈105 20 15
10(C) DNA repair protein RAD50 5,7 Q9JIL8 154 ≈35 84 42
ATP-dependent RNA helicase 
DHX39
Q5U216 49 ≈35 23 41
11(C) Lamin-B1 5,4 P70615 66 ≈70 18 22
12(C) Coiled-coil domain-containing 
protein 41
6,0 Q66H89 69 ≈70 27 25
Notes: 1proteins characterized with a MASCOT total protein score > 50 were 
considered as real and as high confidence proteins; 2Spots corresponds num-
bers in Fig. TBP isolated from rat liver cells (A); rat experimental Zajdela as-
cites hepatoma B); rat experimental G-27 hepatoma (C); 3number of pep-
tides — number of peptides of the protein identified by mass spectrometry 
as peptides belonging to the sequence of identified protein; 4% of the the se-
quence — part of the sequence of identified protein covered by the above — 
mentioned  peptides
Some TBP proteins are identified as RAD50 are 
components of a single protein complex, Mre11-
Rad50-Nbs1 (MRN). The MRN complex consists 
of dimers of each subunit and this heterohexamer 
controls key sensing, signaling, regulation, and effec-
tor responses to DNA double-strand breaks including 
ATM activation, homologous recombinational repair, 
microhomology-mediated end joining and, in some 
organisms, non-homologous end joining. To organize 
the MRN complex, the Mre11 exonuclease directly 
binds Nbs1, DNA, and Rad50. Rad50, a structural 
maintenance of chromosome (SMC) related protein, 
employs its ATP-binding cassette (ABC) ATPase, 
Zn hook, and coiled coils to bridge DSBs and fa-
cilitate DNA end processing by Mre11 [18, 19]. Thus 
RAD50 keeps attached to DNA a huge multiprotein 
complex.
 Structural maintenance of chromosomes protein 
1A (SMC1A) is structural component of cohesin. Co-
hesin regulates sister chromatid cohesion during the 
mitosis and meiosis. In addition, cohesin has been 
demonstrated to play a critical role in the regulation 
of gene expression. Furthermore, multiple proteins 
in the cohesin pathway are also involved in addi-
tional fundamental biological events such as double 
strand DNA break repair, chromatin remodeling and 
maintaining genomic stability. Composed of several 
essential subunits, cohesin forms a ring-like complex 
that is thought to embrace sister chromatids, thereby 
physically linking them until their timely segregation 
during cell division [20]. 
Several identified polypeptides were  homolo-
gous to RNA helicases (Spots No. 4 and 10). These 
proteins are now of major interest because they are 
known to play important roles in virtually all aspects 
of RNA synthesis and function, including nuclear 
transcription, pre mRNA splicing, ribosome biogen-
esis, nucleocytoplasmic transport, translation, RNA 
decay and organellar gene expression, processes that 
involve multi-step association/ dissociation of large 
RNP complexes as well as the modulation of complex 
RNA structure [21]. Helicases were resently identified 
among barely TBP [10]. 
Lamin B1 is identified exclusively in preparations 
of tumour TBP (Spots No.5 and 11). Traditionally lamins 
were not considered to form very tight complexes with 
DNA. Actually besides being structural components 
of the nuclear envelope lamins turn out to be involved 
in multiple functions and complex interactions with 
other nuclear proteins and DNA. Lamin B1 is involved 
in sequestration of the transcription factors [22]. Lamin 
B1 maintains the functional plasticity of nucleoli inter-
acting with nucleophosmin, intriguingly nucleophos-
min also revealed in one of the spots [23]. In whole 
the nuclear envelope is considered to be a signalling 
node in development and disease [24, 25]. Some data 
indicate possible involvement of lamins and lamin 
receptors in tumour phenotype development [26]. 
Lamin B interacts with DNA via lamin B receptor [27]. 
The interaction occurs via linker DNA and is enhanced 
by DNA curvatures [28]. Certain genomic elements are 
attached to the nuclear lamina, this contributes to the 
spatial organization of chromosomes inside the nucle-
us. Sequences in the human genome that interact with 
the nuclear lamina in vivo have been already identified. 
A map of the interaction sites of the entire genome 
with the nuclear lamina shows that genome-lamina 
interactions occur through more than 1,300 sharply 
defined large domains 0.1–10 megabases in size. 
These lamina-associated domains (LADs) are typi-
fied by low gene-expression levels, indicating that 
LADs represent a repressive chromatin environment. 
The borders of LADs are demarcated by the insulator 
protein CTCF, by promoters that are oriented away 
from LADs, or by CpG islands, suggesting possible 
mechanisms of LAD confinement [29]. Interaction 
of silenced genes with the nuclear lamina is mediated 
by lamins [30]. Probably presence of Lamin B in the 
TBP preparations of rat hepatomas indicates tumour-
progression associated modifications of the above 
DNA-lamin interactions.
The nucleus contains many potential cancer 
markers [1, 3]. The present study was designed 
to determine changes in TBP patterns from normal 
and malignant cells. We have analyzed TBP from rat 
liver and rat experimental hepatomas (Zajdela ascites 
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hepatoma and hepatoma G-27) to search for candi-
dates of malignant transformation markers. Altogether 
we have identified some TBP by mass spectrometry. 
TBP pattern proteome alterations of normal and malig-
nant cells evidenced by comparative 2DE-gel analysis 
proved that proteomic approach may be promising 
in development of biomarkers. At present the nature 
and function of many TBP have not been established, 
awaiting further investigation. Function of the tightly 
bound to DNA proteins in vivo remains an open ques-
tion. Lamins were identified as prospective markers, 
however furher research is nessesery to test their utility 
for practical applications. Although the further elucida-
tion of the TBP potential for biomarker trawling is nec-
essary due to the limited number of identified TBP, 
the proteomic approach has proven to be promising.
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